Abstract
The pathogenesis of autism spectrum disorders (ASD) is not completely understood, but there is evidence of associations with altered immune responses. The aim of this study was to determine the serum levels of various cytokines in children with ASD and in healthy controls, in order to determine their role in ASD and its diagnostic subgroups. Sixty-five ASD patients were enrolled from an epidemiological survey in Norway, of which 30 were diagnosed with childhood autism, 16 with Asperger syndrome, 12 with atypical autism, 1 with Rett syndrome, and 6 with another ASD diagnosis. The serum levels of 12 cytokines were measured in all of the patients and in 30 healthy children. The cytokine levels did not differ significantly between the ASD group and the healthy controls. However, the interleukin-8 (IL-8) level was significantly higher (6.82 vs 4.58 pg/ml, p = 0.017) while that of IL-10 was significantly lower (2.24 vs 6.49 pg/ml, p = 0.009) in patients with childhood autism than in controls. Furthermore, the IL-8 level was significantly higher in childhood autism than in Asperger syndrome (6.82 vs 4.05 pg/ml, p = 0.013). Our study shows that the cytokine profile of children diagnosed with ASD, regardless of the subdiagnosis, does not differ from healthy controls. However, differentiation into different diagnostic subgroups reveals significantly different levels of IL-8 and IL-10. This indicates that different mechanisms may underlie the different ASD subdiagnoses. Future research into the pathophysiological mechanisms of ASD should pay more attention to the different subdiagnoses of ASD.
Similar content being viewed by others
References
Ashwood P et al (2011a) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25:40–5
Ashwood P et al (2011b) Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol 232:196–9
Atladottir HO et al (2009) Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 124:687–94
Baird G et al (2006) Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 368:210–5
Bauer S, Kerr BJ, Patterson PH (2007) The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci 8:221–32
Braunschweig D, Van de Water J (2012) Maternal autoantibodies in autism. Arch Neurol 69:693–9
Braunschweig D et al (2008) Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 29:226–31
Brown AS (2012) Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol 72:1272–6
Coleman M, Gillberg C, Gillberg, C.B.o.t.a.s (2012). The autisms, Vol., Oxford University Press, New York; Oxford
Comi AM et al (1999) Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 14:388–94
Cordeiro CN, Tsimis M, Burd I (2015) Infections and brain development. Obstet Gynecol Surv 70:644–55
Croen LA et al (2005) Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case–control study. Arch Pediatr Adolesc Med 159:151–7
Croen LA et al (2008) Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol Psychiatry 64:583–8
Croonenberghs J et al (2002) Activation of the inflammatory response system in autism. Neuropsychobiology 45:1–6
Dantzer R (2004) Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 500:399–411
Emanuele E et al (2010) Low-grade endotoxemia in patients with severe autism. Neurosci Lett 471:162–5
Fombonne E (2009) Epidemiology of pervasive developmental disorders. Pediatr Res 65:591–8
Gesundheit B et al (2013) Immunological and autoimmune considerations of autism spectrum disorders. J Autoimmun 44:1–7
Isaksen J et al (2012) Observed prevalence of autism spectrum disorders in two Norwegian counties. Eur J Paediatr Neurol 16:592–8
Isaksen J et al (2013) Children with autism spectrum disorders—the importance of medical investigations. Eur J Paediatr Neurol 17:68–76
Jarskog LF et al (1997) Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro. Int J Dev Neurosci 15:711–6
Levy SE, Mandell DS, Schultz RT (2009) Autism Lancet 374:1627–38
Masi A, Quintana, DS, (2015). Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. 20, 440–6
Mead J, Ashwood P (2015) Evidence supporting an altered immune response in ASD. Immunol Lett 163:49–55
Meyer U, Feldon J, Yee BK (2009) A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 35:959–72
Mouridsen SE et al (2007) Autoimmune diseases in parents of children with infantile autism: a case–control study. Dev Med Child Neurol 49:429–32
Mousa A et al (1999) Human first trimester forebrain cells express genes for inflammatory and anti-inflammatory cytokines. Cytokine 11:55–60
Napolioni V et al (2013) Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder. J Neuroinflammation 10:38
Nawa H, Takei N (2006) Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res 56:2–13
Nordahl CW et al (2013) Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder. Brain Behav Immun 30:61–5
Onore C, Careaga M, Ashwood P (2012) The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26:383–92
Persico AM, Bourgeron T (2006) Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 29:349–58
Rogers SJ (2004) Developmental regression in autism spectrum disorders. Ment Retard Dev Disabil Res Rev 10:139–43
Rose D, Ashwood P (2014) Potential cytokine biomarkers in autism spectrum disorders. Biomark Med 8:1171–81
Singer HS et al (2008) Antibodies against fetal brain in sera of mothers with autistic children. J Neuroimmunol 194:165–72
Singh VK et al (1991) Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clin Immunol Immunopathol 61:448–55
Spence SJ, Schneider MT (2009) The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatr Res 65:599–606
Suzuki K et al (2011) Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One 6, e20470
Sweeten TL et al (2004) High nitric oxide production in autistic disorder: a possible role for interferon-gamma. Biol Psychiatry 55:434–7
Taylor LE, Swerdfeger AL, Eslick GD (2014) Vaccines are not associated with autism: an evidence-based meta-analysis of case–control and cohort studies. Vaccine 32:3623–9
Xu N, Li X, Zhong Y (2015) Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders. Mediat Inflamm 2015:531518
Zimmerman AW et al (2005) Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol 33:195–201
Acknowledgments
The authors gratefully acknowledge the assistance of pediatrician Pernille Tryli, diagnostic teams at the Departments of Habilitation at Lillehammer and Ottestad, and laboratory personnel in the hospitals at Lillehammer, Gjøvik, and Elverum. The study was supported by Innlandet Hospital research foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Written statements of informed consent were obtained from the parents before any child (ASD or control) was included in the project. The regional Committee for Research Ethics (REK) provided approval for the study to be performed.
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Bryn, V., Aass, H.C.D., Skjeldal, O.H. et al. Cytokine Profile in Autism Spectrum Disorders in Children. J Mol Neurosci 61, 1–7 (2017). https://doi.org/10.1007/s12031-016-0847-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-016-0847-z